Search Results - "Zwiech, Rafal"

Refine Results
  1. 1
  2. 2

    Absence of C4d urinary excretion in the early post-transplant period is associated with improved long-term kidney graft survival by Zwiech, Rafał

    Published in Transplant immunology (01-01-2014)
    “…Abstract Introduction C4d urinary excretion varies according to the risk of graft rejection or progression of chronic allograft nephropathy, but its influence…”
    Get full text
    Journal Article
  3. 3

    Effects of the Malnutrition-Eat Additional Meal (MEAM) Diet on the Serum Levels of Albumin and C-Reactive Protein in Hemodialysis Patients by Kozlowska, Lucyna, Gromadzinska, Jolanta, Zwiech, Rafal, Zbrog, Zbigniew, Wasowicz, Wojciech

    Published in Nutrients (01-12-2022)
    “…The main objective of this project was to evaluate the efficiency of two kinds of nutritional intervention implemented in hemodialysis patients for 24 weeks…”
    Get full text
    Journal Article
  4. 4

    A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients by Zwiech, Rafał, Adelt, Maria, Chrul, Sławomir

    Published in American journal of therapeutics (01-03-2016)
    “…Catheter-related bacteremia (CRB) is a typical complication of hemodialysis catheter use. Catheter lumen colonization by pathogens is regarded as a direct…”
    Get full text
    Journal Article
  5. 5

    Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis by Zwiech, Rafał

    Published in BMC immunology (14-08-2015)
    “…Macrophage migration inhibitory factor (MIF) is a cytokine that shares many activities with other pro-inflammatory cytokines in primary glomerulonephritis…”
    Get full text
    Journal Article
  6. 6

    Serum microRNA profiles in patients with autosomal dominant polycystic kidney disease show systematic dysregulation partially reversible by hemodialysis by Małachowska, Beata, Tkaczyk, Marcin, Chrul, Sławomir, Zwiech, Rafał, Młynarski, Wojciech, Fendler, Wojciech

    Published in Archives of medical science (01-01-2021)
    “…The impact of autosomal dominant polycystic kidney disease (ADPKD) on serum microRNAs (miRNA) is unknown. For profiling experiment we recruited 30 patients…”
    Get full text
    Journal Article
  7. 7

    A potential link between AQP3 and SLC14A1 gene expression level and clinical parameters of maintenance hemodialysis patients by Zwiech, Rafał, Bruzda-Zwiech, Agnieszka, Balcerczak, Ewa, Szczepańska, Joanna, Krygier, Adrian, Małachowska, Beata, Michałek, Dominika, Szmajda-Krygier, Dagmara

    Published in BMC nephrology (29-08-2022)
    “…The transport of water and urea through the erythrocyte membrane is facilitated by aquaporins such as aquaglyceroporin (AQP3), and type B urea transporters…”
    Get full text
    Journal Article
  8. 8

    Does oral health contribute to post-transplant complications in kidney allograft recipients? by Zwiech, Rafał, Bruzda-Zwiech, Agnieszka

    Published in Acta odontologica Scandinavica (01-05-2013)
    “…The significant number of complications in kidney graft recipients can not be easily explained. The paper assesses whether poor oral health increases the risk…”
    Get more information
    Journal Article
  9. 9

    Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients by Bruzda-Zwiech, A, Szczepańska, J, Zwiech, R

    “…In hemodialysis (HD) patients, xerostomia and hyposalivation may intensify sensations of thirst, and contribute to the intake of fluids and excessive…”
    Get full text
    Journal Article
  10. 10

    The Effects of Two Kinds of Dietary Interventions on Serum Metabolic Profiles in Haemodialysis Patients by Kozlowska, Lucyna, Jagiello, Karolina, Ciura, Krzesimir, Sosnowska, Anita, Zwiech, Rafal, Zbrog, Zbigniew, Wasowicz, Wojciech, Gromadzinska, Jolanta

    Published in Biomolecules (Basel, Switzerland) (18-05-2023)
    “…The goal of this study was to evaluate the effects of two kinds of 24-week dietary interventions in haemodialysis patients, a traditional nutritional…”
    Get full text
    Journal Article
  11. 11

    Sodium gradient, xerostomia, thirst and inter-dialytic excessive weight gain: a possible relationship with hyposalivation in patients on maintenance hemodialysis by Bruzda-Zwiech, Agnieszka, Szczepańska, Joanna, Zwiech, Rafał

    Published in International urology and nephrology (01-07-2014)
    “…Purpose The aim of the study was to assess whether hyposalivation is linked with increased thirst sensation and weight gain in hemodialysis (HD) patients and…”
    Get full text
    Journal Article
  12. 12

    Autonomic neuropathy in hemodialysis patients: questionnaires versus clinical tests by Nowicki, Michał, Zwiech, Rafał, Dryja, Przemysław, Sobański, Wiktor

    Published in Clinical and experimental nephrology (01-04-2009)
    “…Aim Uremic neuropathy (UN) is a typical complication of long-term dialysis therapy and may manifest as distal, symmetric, and both senso-motoric and autonomic…”
    Get full text
    Journal Article
  13. 13

    S-Fas urinary excretion helps to predict the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis by Zwiech, Rafał

    Published in Journal of Korean medical science (01-10-2013)
    “…Deregulation of soluble apoptosis stimulating fragment (sFas) plays an important role in glomerulonephritis (GN). The study assed the influence of…”
    Get full text
    Journal Article
  14. 14

    Predictive value of conjointly examined IL-1ra, TNF-R I, TNF-R II, and RANTES in patients with primary glomerulonephritis by Zwiech, Rafał

    Published in Journal of Korean medical science (01-02-2013)
    “…Interleukin-1 receptor antagonist (IL-1ra), tumor necrosis factor soluble receptors (sTNF-R) type I and II, and regulated upon activation, normal T-cell…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Safety and Efficacy of Vadadustat Once-Daily and 3-Times-Weekly in Dialysis-Dependent Chronic Kidney Disease Patients with Anemia by Kooienga, Laura, Burke, Steven, Kathresal, Amarnath, Luo, Wenli, Yang, Zhihui, Zhang, Zhiqun, Zwiech, Rafal, Hernandez, German T

    Published in Kidney360 (04-09-2024)
    “…Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor for treating anemia in chronic kidney disease (CKD). This study investigated safety…”
    Get full text
    Journal Article
  19. 19
  20. 20